Literature DB >> 31986893

MicroRNA-370-3p inhibits cell proliferation and induces chronic myelogenous leukaemia cell apoptosis by suppressing PDLIM1/Wnt/β-catenin signaling.

L M Li1, F J Luo1, X Song1.   

Abstract

Growing evidence has suggested that microRNA-370-3p (miR-370-3p) is downregulated and acts as a suppressor in several cancers. However, the role of miR-370-3p in chronic myeloid leukemia (CML) remains unknown. Here, the expression level and molecular mechanism of miR-370-3p in CML were investigated. Firstly, the expression of miR-370-3p has markedly decreased in the peripheral blood mononuclear cells (PBMCs) of patients with CML and in cell lines. Moreover, miR-370-3p in CML cells upregulated and downregulated proliferation and apoptosis, respectively. Notably, miR-370-3p directly targeted the 3'-untranslated region of PDZ and LIM domain protein 1 (PDLIM1). A negative correlation was observed between the levels of miR-370-3p and PDLIM1 in the PBMCs of patients with CML and healthy volunteers. PDLIM1 was shown to have an oncogenic role in CML cells by promoting proliferation and suppressing apoptosis. Finally, the miR-370-3p-PDLIM1-Wnt/β-catenin signaling axis was indicated to play an important role in CML progression.

Entities:  

Year:  2020        PMID: 31986893     DOI: 10.4149/neo_2020_190612N506

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  6 in total

1.  CLP36 promotes p53 deficient sarcoma progression through suppression of atrophin-1 interacting protein-4 (AIP-4)-dependent degradation of YAP1.

Authors:  Yixuan Lu; Yongxin Mu; Ju Chen; Xinyuan Guan; Ling Guo; Chuanyue Wu
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

Review 2.  MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment.

Authors:  Shahzad Nawaz Syed; Bernhard Brüne
Journal:  Cancers (Basel)       Date:  2020-04-08       Impact factor: 6.639

3.  MicroRNA-489-3p plays a significant role in congenital hypothyroidism through regulating neuronal cell apoptosis via targeting translationally controlled tumor protein 1.

Authors:  Qin Liu; Yuehong Li; Yong Zhou
Journal:  Exp Ther Med       Date:  2021-01-20       Impact factor: 2.447

4.  Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.

Authors:  Cuipeng Qiu; Yaru Duan; Bofei Wang; Jianxiang Shi; Peng Wang; Hua Ye; Liping Dai; Jianying Zhang; Xiao Wang
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

5.  miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway.

Authors:  Yeru Tan; Yuehua Li; Hongbo Zhu; Xiaoping Wu; Kai Mei; Pian Li; Qiao Yang
Journal:  J Oncol       Date:  2022-09-17       Impact factor: 4.501

6.  Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.

Authors:  Hui Xiong; Jinsong Yu; Guangwei Jia; Yang Su; Jianliang Zhang; Qiu Xu; Xiaoxiong Sun
Journal:  Hum Cell       Date:  2021-08-03       Impact factor: 4.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.